• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通用机制将三核苷酸疾病中的基因型与表型联系起来。

A universal mechanism ties genotype to phenotype in trinucleotide diseases.

作者信息

Kaplan Shai, Itzkovitz Shalev, Shapiro Ehud

机构信息

Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.

出版信息

PLoS Comput Biol. 2007 Nov;3(11):e235. doi: 10.1371/journal.pcbi.0030235. Epub 2007 Oct 16.

DOI:10.1371/journal.pcbi.0030235
PMID:18039028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2082501/
Abstract

Trinucleotide hereditary diseases such as Huntington disease and Friedreich ataxia are cureless diseases associated with inheriting an abnormally large number of DNA trinucleotide repeats in a gene. The genes associated with different diseases are unrelated and harbor a trinucleotide repeat in different functional regions; therefore, it is striking that many of these diseases have similar correlations between their genotype, namely the number of inherited repeats and age of onset and progression phenotype. These correlations remain unexplained despite more than a decade of research. Although mechanisms have been proposed for several trinucleotide diseases, none of the proposals, being disease-specific, can account for the commonalities among these diseases. Here, we propose a universal mechanism in which length-dependent somatic repeat expansion occurs during the patient's lifetime toward a pathological threshold. Our mechanism uniformly explains for the first time to our knowledge the genotype-phenotype correlations common to trinucleotide disease and is well-supported by both experimental and clinical data. In addition, mathematical analysis of the mechanism provides simple explanations to a wide range of phenomena such as the exponential decrease of the age-of-onset curve, similar onset but faster progression in patients with Huntington disease with homozygous versus heterozygous mutation, and correlation of age of onset with length of the short allele but not with the long allele in Friedreich ataxia. If our proposed universal mechanism proves to be the core component of the actual mechanisms of specific trinucleotide diseases, it would open the search for a uniform treatment for all these diseases, possibly by delaying the somatic expansion process.

摘要

三核苷酸遗传性疾病,如亨廷顿舞蹈症和弗里德赖希共济失调症,是与基因中异常大量的DNA三核苷酸重复序列遗传相关的无法治愈的疾病。与不同疾病相关的基因彼此无关,且在不同的功能区域含有三核苷酸重复序列;因此,令人惊讶的是,这些疾病中的许多在其基因型(即遗传重复序列的数量)与发病年龄和疾病进展表型之间具有相似的相关性。尽管经过了十多年的研究,这些相关性仍无法得到解释。虽然已经针对几种三核苷酸疾病提出了一些机制,但这些特定于某种疾病的机制都无法解释这些疾病之间的共性。在此,我们提出一种通用机制,即在患者的一生中会发生长度依赖性的体细胞重复序列扩增,直至达到病理阈值。据我们所知,我们的机制首次统一解释了三核苷酸疾病共有的基因型 - 表型相关性,并且得到了实验和临床数据的有力支持。此外,对该机制的数学分析为广泛的现象提供了简单的解释,例如发病年龄曲线的指数下降、亨廷顿舞蹈症纯合突变患者与杂合突变患者发病相似但进展更快,以及弗里德赖希共济失调症中发病年龄与短等位基因长度相关而与长等位基因长度无关。如果我们提出的通用机制被证明是特定三核苷酸疾病实际机制的核心组成部分,那么可能通过延缓体细胞扩增过程,开启针对所有这些疾病的统一治疗方法的探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/177885b923b2/pcbi.0030235.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/681cc0b68dca/pcbi.0030235.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/9524f0e27e11/pcbi.0030235.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/014abea09a81/pcbi.0030235.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/c9f72c96e5c5/pcbi.0030235.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/177885b923b2/pcbi.0030235.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/681cc0b68dca/pcbi.0030235.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/9524f0e27e11/pcbi.0030235.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/014abea09a81/pcbi.0030235.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/c9f72c96e5c5/pcbi.0030235.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ce9/2098862/177885b923b2/pcbi.0030235.g005.jpg

相似文献

1
A universal mechanism ties genotype to phenotype in trinucleotide diseases.一种通用机制将三核苷酸疾病中的基因型与表型联系起来。
PLoS Comput Biol. 2007 Nov;3(11):e235. doi: 10.1371/journal.pcbi.0030235. Epub 2007 Oct 16.
2
Trinucleotide expansion in disease: why is there a length threshold?疾病中的三核苷酸重复扩增:为何存在长度阈值?
Curr Opin Genet Dev. 2014 Jun;26:131-40. doi: 10.1016/j.gde.2014.07.003. Epub 2014 Oct 1.
3
250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.肌强直性营养不良蛋白激酶基因(DMPK)中250个CUG重复序列是青少年-成人型DM1发病时重复序列扩增大小与发病年龄相关性的一个阈值。
Hum Mutat. 2002 Feb;19(2):131-9. doi: 10.1002/humu.10027.
4
Rare fragile sites.罕见脆性位点
Cytogenet Genome Res. 2003;100(1-4):77-84. doi: 10.1159/000072840.
5
[Medical pathology due to trinucleotide repeats].[三核苷酸重复所致的医学病理学]
Gac Med Mex. 1999 Jan-Feb;135(1):53-65.
6
Sequence variation in GAA repeat expansions may cause differential phenotype display in Friedreich's ataxia.GAA重复序列扩增中的序列变异可能导致弗里德赖希共济失调中不同的表型表现。
Mov Disord. 2001 Nov;16(6):1153-8. doi: 10.1002/mds.1210.
7
Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients.弗里德赖希共济失调复合杂合子患者的基因型和表型分析。
Hum Genet. 2000 Jan;106(1):86-92. doi: 10.1007/s004399900201.
8
Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.R6/2亨廷顿病小鼠等位基因系列中年龄、组织和长度依赖性双向体细胞CAG•CTG重复序列不稳定性
Neurobiol Dis. 2015 Apr;76:98-111. doi: 10.1016/j.nbd.2015.01.004. Epub 2015 Feb 3.
9
Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients.伊朗弗里德赖希共济失调患者DNA聚合酶基因(POLG)的三核苷酸CAG重复序列与发病年龄之间的关联。
Neurol Sci. 2008 Dec;29(6):489-93. doi: 10.1007/s10072-008-1026-y. Epub 2008 Nov 28.
10
Very late-onset Friedreich ataxia despite large GAA triplet repeat expansions.尽管存在大量GAA三联体重复扩增,但仍为迟发性弗里德赖希共济失调。
Arch Neurol. 2000 Feb;57(2):246-51. doi: 10.1001/archneur.57.2.246.

引用本文的文献

1
is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonism.是X连锁肌张力障碍帕金森综合征中体细胞重复不稳定性的遗传修饰因子。
bioRxiv. 2025 May 16:2025.05.14.653432. doi: 10.1101/2025.05.14.653432.
2
Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective.短串联重复序列疾病中的嵌合现象:临床视角
Genes (Basel). 2025 Feb 13;16(2):216. doi: 10.3390/genes16020216.
3
Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice.不同的错配修复复合基因设定神经元CAG重复扩增速率,以驱动亨廷顿病小鼠的选择性发病机制。

本文引用的文献

1
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease.在果蝇多聚谷氨酰胺疾病模型中,CREB结合蛋白调节重复序列不稳定性。
Science. 2007 Mar 30;315(5820):1857-9. doi: 10.1126/science.1139517. Epub 2007 Mar 1.
2
The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction.
Eur J Neurol. 2006 Apr;13(4):408-15. doi: 10.1111/j.1468-1331.2006.01264.x.
3
The association of CAG repeat length with clinical progression in Huntington disease.亨廷顿病中CAG重复序列长度与临床进展的关联。
Cell. 2025 Mar 20;188(6):1524-1544.e22. doi: 10.1016/j.cell.2025.01.031. Epub 2025 Feb 11.
4
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis.在亨廷顿病临床运动诊断前数十年,血液中的体细胞CAG重复序列扩增与神经退行性变的生物标志物相关。
Nat Med. 2025 Mar;31(3):807-818. doi: 10.1038/s41591-024-03424-6. Epub 2025 Jan 17.
5
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease.长链体细胞DNA重复序列扩增导致亨廷顿舞蹈症中的神经退行性变。
Cell. 2025 Feb 6;188(3):623-639.e19. doi: 10.1016/j.cell.2024.11.038. Epub 2025 Jan 16.
6
Recent Advances in the Genetics of Ataxias: An Update on Novel Autosomal Dominant Repeat Expansions.共济失调遗传学的最新进展:新型常染色体显性重复序列扩增的最新情况
Curr Neurol Neurosci Rep. 2025 Jan 16;25(1):16. doi: 10.1007/s11910-024-01400-8.
7
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding.通过转录抑制和直接CAG重复序列结合抑制亨廷顿舞蹈病的体细胞不稳定性
bioRxiv. 2024 Nov 4:2024.11.04.619693. doi: 10.1101/2024.11.04.619693.
8
Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications.亨廷顿病中的神经炎症蛋白:对发病机制、诊断和治疗意义的深入了解。
Int J Mol Sci. 2024 Nov 2;25(21):11787. doi: 10.3390/ijms252111787.
9
Somatic instability of the FGF14-SCA27B GAA•TTC repeat reveals a marked expansion bias in the cerebellum.FGF14-SCA27B GAA•TTC重复序列的体细胞不稳定性表明小脑存在明显的扩增偏向。
Brain. 2025 Apr 3;148(4):1258-1270. doi: 10.1093/brain/awae312.
10
Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease.年龄相关的 ATXN3 CAG 重复在脊髓小脑共济失调 3 型/马查多-约瑟夫病个体的血液和口腔拭子 DNA 中的体细胞扩增。
Hum Genet. 2024 Nov;143(11):1363-1378. doi: 10.1007/s00439-024-02698-7. Epub 2024 Oct 8.
Neurology. 2006 Apr 11;66(7):1016-20. doi: 10.1212/01.wnl.0000204230.16619.d9.
4
Diseases of unstable repeat expansion: mechanisms and common principles.不稳定重复序列扩增疾病:机制与共同原理
Nat Rev Genet. 2005 Oct;6(10):743-55. doi: 10.1038/nrg1691.
5
Repeat instability: mechanisms of dynamic mutations.重复序列不稳定性:动态突变的机制
Nat Rev Genet. 2005 Oct;6(10):729-42. doi: 10.1038/nrg1689.
6
History of genetic disease: the molecular genetics of Huntington disease - a history.遗传疾病史:亨廷顿舞蹈症的分子遗传学——一段历史。
Nat Rev Genet. 2005 Oct;6(10):766-73. doi: 10.1038/nrg1686.
7
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblasts.源自父本CAG34等位基因的新亨廷顿病突变,在连续传代的淋巴母细胞中表现出体细胞长度变异。
Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):127-30. doi: 10.1002/ajmg.b.30125.
8
Pathogenic RNA repeats: an expanding role in genetic disease.致病性RNA重复序列:在遗传疾病中的作用不断扩大。
Trends Genet. 2004 Oct;20(10):506-12. doi: 10.1016/j.tig.2004.08.004.
9
Trinucleotide repeats and neurodegenerative disease.三核苷酸重复序列与神经退行性疾病。
Brain. 2004 Nov;127(Pt 11):2385-405. doi: 10.1093/brain/awh278. Epub 2004 Aug 25.
10
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.常染色体显性遗传性小脑共济失调:临床特征、遗传学及发病机制
Lancet Neurol. 2004 May;3(5):291-304. doi: 10.1016/S1474-4422(04)00737-9.